Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Urinary cross-linked carboxyterminal telopeptide, a bone resorption marker, decreases after vaso-occlusive crises in adults with sickle cell disease.

Adesina OO, Jenkins IC, Wu QV, Fung EB, Narla RR, Lipkin EW, Mahajan K, Konkle BA, Kruse-Jarres R.

Blood Cells Mol Dis. 2020 Feb;80:102369. doi: 10.1016/j.bcmd.2019.102369. Epub 2019 Oct 24.

PMID:
31677454
2.

Precision of the Hologic DXA in the Assessment of Visceral Adipose Tissue.

Goldberg EK, Fung EB.

J Clin Densitom. 2019 Mar 20. pii: S1094-6950(19)30002-2. doi: 10.1016/j.jocd.2019.03.005. [Epub ahead of print]

PMID:
30992223
3.

Effect of prenatal calcium supplementation on bone during pregnancy and 1 y postpartum.

Cullers A, King JC, Van Loan M, Gildengorin G, Fung EB.

Am J Clin Nutr. 2019 Jan 1;109(1):197-206. doi: 10.1093/ajcn/nqy233.

PMID:
30649176
4.

Vertebral Bone Density Measurements by DXA are Influenced by Hepatic Iron Overload in Patients with Hemoglobinopathies.

Allard HM, Calvelli L, Weyhmiller MG, Gildengorin G, Fung EB.

J Clin Densitom. 2019 Jul - Sep;22(3):329-337. doi: 10.1016/j.jocd.2018.07.001. Epub 2018 Jul 11.

PMID:
30122533
5.

The Answer is Vitamin D! From Pediatrics to Geriatrics in Orthopaedics.

Minkowitz B, Sawyer A, Fung EB, Dvorzhinskiy A, Lane JM.

Instr Course Lect. 2018 Feb 15;67:529-541.

PMID:
31411437
6.

Dietary nonheme iron is equally bioavailable from ferritin or ferrous sulfate in thalassemia intermedia.

Khurana M, Fung EB, Vichinsky EP, Theil EC.

Pediatr Hematol Oncol. 2017 Nov;34(8):455-467. doi: 10.1080/08880018.2017.1395935. Epub 2017 Dec 12.

PMID:
29232169
7.

The importance of nutrition for health in patients with transfusion-dependent thalassemia.

Fung EB.

Ann N Y Acad Sci. 2016 Mar;1368(1):40-8. doi: 10.1111/nyas.13003. Epub 2016 Jan 29. Review.

PMID:
26824448
8.

Guidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort.

Tubman VN, Fung EB, Vogiatzi M, Thompson AA, Rogers ZR, Neufeld EJ, Kwiatkowski JL; Thalassemia Clinical Research Network.

J Pediatr Hematol Oncol. 2015 Apr;37(3):e162-9. doi: 10.1097/MPH.0000000000000307.

9.

Zinc status affects glucose homeostasis and insulin secretion in patients with thalassemia.

Fung EB, Gildengorin G, Talwar S, Hagar L, Lal A.

Nutrients. 2015 Jun 2;7(6):4296-307. doi: 10.3390/nu7064296.

10.

Effects of early vitamin D deficiency rickets on bone and dental health, growth and immunity.

Zerofsky M, Ryder M, Bhatia S, Stephensen CB, King J, Fung EB.

Matern Child Nutr. 2016 Oct;12(4):898-907. doi: 10.1111/mcn.12187. Epub 2015 Apr 7.

11.

The effect of low magnitude mechanical stimulation (LMMS) on bone density in patients with Rett syndrome: a pilot and feasibility study.

Afzal SY, Wender AR, Jones MD, Fung EB, Pico EL.

J Pediatr Rehabil Med. 2014;7(2):167-78. doi: 10.3233/PRM-140286.

PMID:
25096869
12.

Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI.

Stevenson DA, Rudser K, Kunin-Batson A, Fung EB, Viskochil D, Shapiro E, Orchard PJ, Whitley CB, Polgreen LE.

J Pediatr Rehabil Med. 2014;7(2):159-65. doi: 10.3233/PRM-140285.

13.

Bone health in children with special health care needs.

Fung EB.

J Pediatr Rehabil Med. 2014;7(2):107-9. doi: 10.3233/PRM-140279. No abstract available.

PMID:
25096862
14.

Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial.

Fung EB, Kwiatkowski JL, Huang JN, Gildengorin G, King JC, Vichinsky EP.

Am J Clin Nutr. 2013 Oct;98(4):960-71. doi: 10.3945/ajcn.112.049221. Epub 2013 Aug 14.

15.

The effect of whole body vibration therapy on bone density in patients with thalassemia: a pilot study.

Fung EB, Gariepy CA, Sawyer AJ, Higa A, Vichinsky EP.

Am J Hematol. 2012 Oct;87(10):E76-9. doi: 10.1002/ajh.23305. Epub 2012 Aug 7. No abstract available.

16.

Feto-maternal vitamin D status and infant whole-body bone mineral content in the first weeks of life.

Dror DK, King JC, Durand DJ, Fung EB, Allen LH.

Eur J Clin Nutr. 2012 Sep;66(9):1016-9. doi: 10.1038/ejcn.2012.79. Epub 2012 Jul 11.

PMID:
22781021
17.

Role of calcium during pregnancy: maternal and fetal needs.

Hacker AN, Fung EB, King JC.

Nutr Rev. 2012 Jul;70(7):397-409. doi: 10.1111/j.1753-4887.2012.00491.x. Review.

PMID:
22747842
18.

Inadequate dietary intake in patients with thalassemia.

Fung EB, Xu Y, Trachtenberg F, Odame I, Kwiatkowski JL, Neufeld EJ, Thompson AA, Boudreaux J, Quinn CT, Vichinsky EP; Thalassemia Clinical Research Network.

J Acad Nutr Diet. 2012 Jul;112(7):980-90. doi: 10.1016/j.jand.2012.01.017. Epub 2012 May 1.

19.

Evidence of associations between feto-maternal vitamin D status, cord parathyroid hormone and bone-specific alkaline phosphatase, and newborn whole body bone mineral content.

Dror DK, King JC, Fung EB, Van Loan MD, Gertz ER, Allen LH.

Nutrients. 2012 Feb;4(2):68-77. doi: 10.3390/nu4020068. Epub 2012 Feb 6.

20.

Treatment of vitamin D deficiency in transfusion-dependent thalassemia.

Fung EB, Aguilar C, Micaily I, Haines D, Lal A.

Am J Hematol. 2011 Oct;86(10):871-3. doi: 10.1002/ajh.22117. Epub 2011 Aug 4. No abstract available.

21.

Characterization of low bone mass in young patients with thalassemia by DXA, pQCT and markers of bone turnover.

Fung EB, Vichinsky EP, Kwiatkowski JL, Huang J, Bachrach LK, Sawyer AJ, Zemel BS.

Bone. 2011 Jun 1;48(6):1305-12. doi: 10.1016/j.bone.2011.03.765. Epub 2011 Apr 5.

22.

Rapid remineralization of the distal radius after forearm fracture in children.

Fung EB, Humphrey ML, Gildengorin G, Goldstein N, Hoffinger SA.

J Pediatr Orthop. 2011 Mar;31(2):138-43. doi: 10.1097/BPO.0b013e3182093ddd.

23.

Nutritional deficiencies in patients with thalassemia.

Fung EB.

Ann N Y Acad Sci. 2010 Aug;1202:188-96. doi: 10.1111/j.1749-6632.2010.05578.x.

PMID:
20712792
24.

Dual-energy X-ray absorptiometry with serum ferritin predicts liver iron concentration and changes in concentration better than ferritin alone.

Shepherd JA, Fan B, Lu Y, Marquez L, Salama K, Hwang J, Fung EB.

J Clin Densitom. 2010 Oct-Dec;13(4):399-406. doi: 10.1016/j.jocd.2010.05.003. Epub 2010 Jul 21.

25.

Bone density assessment in patients with mucopolysaccharidosis: A preliminary report from patients with MPS II and VI.

Fung EB, Johnson JA, Madden J, Kim T, Harmatz P.

J Pediatr Rehabil Med. 2010;3(1):13-23.

26.

Relationship between chronic transfusion therapy and body composition in subjects with thalassemia.

Fung EB, Xu Y, Kwiatkowski JL, Vogiatzi MG, Neufeld E, Olivieri N, Vichinsky EP, Giardina PJ; Thalassemia Clinical Research Network.

J Pediatr. 2010 Oct;157(4):641-7, 647.e1-2. doi: 10.1016/j.jpeds.2010.04.064. Epub 2010 Jun 12.

27.

Randomized, controlled trial to examine the impact of providing yogurt to women enrolled in WIC.

Fung EB, Ritchie LD, Walker BH, Gildengorin G, Crawford PB.

J Nutr Educ Behav. 2010 May-Jun;42(3 Suppl):S22-9. doi: 10.1016/j.jneb.2010.02.009.

PMID:
20399406
28.

The work and home activities questionnaire: energy expenditure estimates and association with percent body fat.

Block G, Jensen CD, Block TJ, Norris J, Dalvi TB, Fung EB.

J Phys Act Health. 2009;6 Suppl 1:S61-9.

29.

Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America.

Vogiatzi MG, Macklin EA, Trachtenberg FL, Fung EB, Cheung AM, Vichinsky E, Olivieri N, Kirby M, Kwiatkowski JL, Cunningham M, Holm IA, Fleisher M, Grady RW, Peterson CM, Giardina PJ; Thalassemia Clinical Research Network.

Br J Haematol. 2009 Sep;146(5):546-56. doi: 10.1111/j.1365-2141.2009.07793.x. Epub 2009 Jul 13.

30.

Vitamin C treatment reduces elevated C-reactive protein.

Block G, Jensen CD, Dalvi TB, Norkus EP, Hudes M, Crawford PB, Holland N, Fung EB, Schumacher L, Harmatz P.

Free Radic Biol Med. 2009 Jan 1;46(1):70-7. doi: 10.1016/j.freeradbiomed.2008.09.030. Epub 2008 Oct 10.

31.

Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.

Fung EB, Harmatz PR, Milet M, Balasa V, Ballas SK, Casella JF, Hilliard L, Kutlar A, McClain KL, Olivieri NF, Porter JB, Vichinsky EP; Multi-Center Iron Overload Research Group.

Transfusion. 2008 Sep;48(9):1971-80. doi: 10.1111/j.1537-2995.2008.01775.x. Epub 2008 May 29.

32.

Bone disease in thalassemia: a frequent and still unresolved problem.

Vogiatzi MG, Macklin EA, Fung EB, Cheung AM, Vichinsky E, Olivieri N, Kirby M, Kwiatkowski JL, Cunningham M, Holm IA, Lane J, Schneider R, Fleisher M, Grady RW, Peterson CC, Giardina PJ; Thalassemia Clinical Research Network.

J Bone Miner Res. 2009 Mar;24(3):543-57. doi: 10.1359/jbmr.080505.

33.

The effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level.

Block G, Jensen CD, Morrow JD, Holland N, Norkus EP, Milne GL, Hudes M, Dalvi TB, Crawford PB, Fung EB, Schumacher L, Harmatz P.

Free Radic Biol Med. 2008 Aug 15;45(4):377-84. doi: 10.1016/j.freeradbiomed.2008.04.005. Epub 2008 Apr 16.

34.

Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia.

Fung EB, Harmatz PR, Milet M, Coates TD, Thompson AA, Ranalli M, Mignaca R, Scher C, Giardina P, Robertson S, Neumayr L, Vichinsky EP; Multi-Center Iron Overload Study Group.

Bone. 2008 Jul;43(1):162-168. doi: 10.1016/j.bone.2008.03.003. Epub 2008 Mar 15.

35.

Markers of bone turnover are associated with growth and development in young subjects with sickle cell anemia.

Fung EB, Kawchak DA, Zemel BS, Rovner AJ, Ohene-Frempong K, Stallings VA.

Pediatr Blood Cancer. 2008 Mar;50(3):620-3.

36.

Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.

Fung EB, Harmatz P, Milet M, Ballas SK, De Castro L, Hagar W, Owen W, Olivieri N, Smith-Whitley K, Darbari D, Wang W, Vichinsky E; Multi-Center Study of Iron Overload Research Group.

Am J Hematol. 2007 Apr;82(4):255-65.

37.

Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease.

Fung EB, Harmatz PR, Lee PD, Milet M, Bellevue R, Jeng MR, Kalinyak KA, Hudes M, Bhatia S, Vichinsky EP; Multi-Centre Study of Iron Overload Research Group.

Br J Haematol. 2006 Nov;135(4):574-82. Epub 2006 Oct 10.

PMID:
17054676
38.

Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.

Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M, Madden J, Porter J, Evans P, Vichinsky E, Harmatz P.

Br J Haematol. 2006 Oct;135(2):254-63.

39.

Growth and health in children with moderate-to-severe cerebral palsy.

Stevenson RD, Conaway M, Chumlea WC, Rosenbaum P, Fung EB, Henderson RC, Worley G, Liptak G, O'Donnell M, Samson-Fang L, Stallings VA; North American Growth in Cerebral Palsy Study.

Pediatrics. 2006 Sep;118(3):1010-8.

PMID:
16950992
40.

A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia.

Pakbaz Z, Fischer R, Treadwell M, Yamashita R, Fung EB, Calvelli L, Quirolo K, Foote D, Harmatz P, Vichinsky EP.

Ann N Y Acad Sci. 2005;1054:486-91.

PMID:
16339703
41.

Bone mineral density in children with sickle cell anemia.

Lal A, Fung EB, Pakbaz Z, Hackney-Stephens E, Vichinsky EP.

Pediatr Blood Cancer. 2006 Dec;47(7):901-6.

PMID:
16317761
42.

Prevalence of fractures among the Thalassemia syndromes in North America.

Vogiatzi MG, Macklin EA, Fung EB, Vichinsky E, Olivieri N, Kwiatkowski J, Cohen A, Neufeld E, Giardina PJ.

Bone. 2006 Apr;38(4):571-5. Epub 2005 Nov 17.

43.

Plasma zinc is an insensitive predictor of zinc status: use of plasma zinc in children with sickle cell disease.

Fung EB, Kawchak DA, Zemel BS, Ohene-Frempong K, Stallings VA.

Nutr Clin Pract. 2002 Dec;17(6):365-72.

PMID:
16215013
44.

Interaction of artificial metallic objects with biosusceptometric measurements.

Engelhardt R, Fung EB, Kelly P, Biehl TR, Pakbaz Z, Nielsen P, Harmatz P, Fischer R.

Neurol Clin Neurophysiol. 2004 Nov 30;2004:32.

PMID:
16012652
45.

The new SQUID biosusceptometer at Oakland: first year of experience.

Fung EB, Fischer R, Pakbaz Z, Fagaly RL, Vichinsky E, Starr TN, Ewing T, Paulson DN, Hassenzahl WV, Harmatz P.

Neurol Clin Neurophysiol. 2004 Nov 30;2004:5.

PMID:
16012600
46.

Secondary sexual characteristics in children with cerebral palsy and moderate to severe motor impairment: a cross-sectional survey.

Worley G, Houlihan CM, Herman-Giddens ME, O'Donnell ME, Conaway M, Stallings VA, Chumlea WC, Henderson RC, Fung EB, Rosenbaum PL, Samson-Fang L, Liptak GS, Calvert RE, Stevenson RD.

Pediatrics. 2002 Nov;110(5):897-902.

PMID:
12415027
47.

Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy.

Henderson RC, Lark RK, Gurka MJ, Worley G, Fung EB, Conaway M, Stallings VA, Stevenson RD.

Pediatrics. 2002 Jul;110(1 Pt 1):e5.

PMID:
12093986
48.

A six-month study of growth and energy expenditure in children with cystic fibrosis taking a pulmonary inhalation medication (rhDNase).

Fung EB, Barden EM, Wasserman D, Zemel BS, Heinrich BT, Scanlin TF, Stallings VA.

J Am Coll Nutr. 1999 Aug;18(4):330-8.

PMID:
12038476
49.

Feeding dysfunction is associated with poor growth and health status in children with cerebral palsy.

Fung EB, Samson-Fang L, Stallings VA, Conaway M, Liptak G, Henderson RC, Worley G, O'Donnell M, Calvert R, Rosenbaum P, Chumlea W, Stevenson RD.

J Am Diet Assoc. 2002 Mar;102(3):361-73.

PMID:
11902369
50.

Effect of hydroxyurea therapy on resting energy expenditure in children with sickle cell disease.

Fung EB, Barden EM, Kawchak DA, Zemel BS, Ohene-Frempong K, Stallings VA.

J Pediatr Hematol Oncol. 2001 Dec;23(9):604-8.

PMID:
11902305

Supplemental Content

Support Center